Capital Research Discloses 3.5% Holdings in Establishment Labs (ESTA)

Rhea-AI Filing Summary

Capital Research Global Investors reports beneficial ownership of 1,024,417 shares of Establishment Labs Holdings Inc., equal to 3.5% of 28,917,254 shares outstanding. The filing states that CRGI is a division of Capital Research and Management Company and related investment management entities that provide services under the name "Capital Research Global Investors." CRGI reports sole voting power and sole dispositive power over the 1,024,417 shares.

The filing further certifies the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing is categorized as an investment adviser (Type: IA).

Insights

Financial Analyst

TL;DR: Institutional investor reports a 3.5% stake with sole voting and dispositive power; issuance is a routine disclosure with limited immediate market impact.

Capital Research Global Investors discloses ownership of 1,024,417 shares representing 3.5% of the issuer's outstanding common stock. The filing identifies CRGI as an investment adviser (Type: IA) and shows sole voting and dispositive authority for the reported position. The certification that the position is held in the ordinary course and not for control purposes frames this as a regulatory ownership disclosure rather than an activist or control-seeking move. For investors, the information updates institutional ownership but does not, by itself, indicate a change in control or strategy.

Corporate Governance Expert

TL;DR: A 3.5% stake with sole voting/dispositive power is notable for disclosure but below common thresholds for material control influence.

The Schedule 13G amendment records CRGI's beneficial ownership and confirms sole voting and dispositive power over the reported shares. The filing explicitly states the position was not acquired to influence control, aligning with Schedule 13G filing intent for passive institutional holders. From a governance perspective, the filing signals institutional ownership without triggering typical governance implications that accompany larger, activist stakes.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Establishment Labs Holdings Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G31249108

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G31249108

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,024,417.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,024,417.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,024,417.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.5 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Establishment Labs Holdings Inc.
(b)	Address of issuer's principal executive offices: Building B15 and 25, Coyol Free Zone, Alajuela 20101, Costa Rica
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: G31249108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,024,417 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 1,024,417 shares or 3.5% of the 28,917,254 shares believed to be outstanding.
(b)	Percent of class: 3.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,024,417
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,024,417
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	08/05/2025

FAQ

How many ESTA shares does Capital Research Global Investors report owning?

The filing reports 1,024,417 shares beneficially owned.

What percentage of Establishment Labs (ESTA) does CRGI's holding represent?

The reported holding represents 3.5% of the 28,917,254 shares believed outstanding.

Does CRGI have voting or dispositive power over the shares reported in the ESTA filing?

Yes; CRGI reports sole voting power and sole dispositive power for the 1,024,417 shares.

Was the position acquired to change or influence control of Establishment Labs (ESTA)?

No; the filing certifies the securities are held in the ordinary course of business and not acquired to change or influence control of the issuer.

What type of SEC filing is this and how is CRGI classified?

This is a Schedule 13G amendment reporting beneficial ownership, with the reporting person classified as an investment adviser (Type: IA).